Perspective | N-of-1 trials in cancer drug development

N-of-1 Trials in Cancer Drug Development – Cancer Discovery

Commentary on Twitter

⭐️Just published in @AACR 's highest impact journal Cancer Discovery this week for your #FridayMotivation –> "N-of-1 Trials in Cancer Drug Development"
We propose N-of-1 trials as a departure from the traditional “drug-centric” model to a “patient-centric” model.
N-of-1 trials… pic.twitter.com/Set2jTpTBO

— Vivek Subbiah, MD (@VivekSubbiah) April 21, 2023